Campbell Rogers - 07 Aug 2025 Form 3 Insider Report for Heartflow, Inc. (HTFL)

Role
Chief Medical Officer
Signature
/s/ Angela Ahmad, Attorney-in-Fact for Campbell D.K. Rogers, M.D.
Issuer symbol
HTFL
Transactions as of
07 Aug 2025
Net transactions value
$0
Form type
3
Filing time
07 Aug 2025, 21:14:42 UTC
Previous filing
14 Oct 2021
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rogers Campbell Chief Medical Officer C/O HEARTFLOW, INC., 331 E. EVELYN AVENUE, MOUNTAIN VIEW /s/ Angela Ahmad, Attorney-in-Fact for Campbell D.K. Rogers, M.D. 07 Aug 2025 0001585724

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HTFL Common Stock 22,615 07 Aug 2025 By Campbell Rogers 2019 Irrevocable Trust F1
holding HTFL Common Stock 46,159 07 Aug 2025 By CR Asset Protection Trust of 2023 F1
holding HTFL Common Stock 26,012 07 Aug 2025 By Spouse's Trust F1
holding HTFL Common Stock 50,754 07 Aug 2025 By The Campbell Rogers Revocable Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HTFL Stock Option 07 Aug 2025 Common Stock 39,709 $8.33 Direct F1, F2
holding HTFL Stock Option 07 Aug 2025 Common Stock 43,785 $8.33 Direct F1, F2
holding HTFL Stock Option 07 Aug 2025 Common Stock 2,231 $8.33 Direct F1, F2
holding HTFL Stock Option 07 Aug 2025 Common Stock 3,589 $8.33 Direct F1, F2
holding HTFL Stock Option 07 Aug 2025 Common Stock 235,834 $2.22 Direct F1, F3
holding HTFL Stock Option 07 Aug 2025 Common Stock 6,849 $2.22 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares of common stock and exercise price, as applicable, give effect to the 1-for-2.92 reverse stock split of Heartflow, Inc.'s common stock, which became effective on July 31, 2025.
F2 These stock options are fully exercisable.
F3 The option is vested and exercisable as to 118,494 shares, and the remaining shares will vest and become exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney.